In a recent article on Huffington Post, written by Dr. Howard Fillit, Chief Science Officer of the Alzheimer’s Drug Discovery Foundation (ADDF), the importance of partnerships are explained in how they lead to the success of major initiatives such as TreatFTD – a new program designed to find drug treatments for FTD. In testing for FTD therapeutics, treatments could also be discovered for Alzheimer’s, ALS and other related neurodegenerative diseases. Read the entire article aqui.